Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY2189102 in Type 2 Diabetes Mellitus
NCT00942188Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2009
- Primary completion
- Nov 2010
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ly2189102 in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Jun 2009; status: completed.
02
Drugs
ly2189102
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00942188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00942188.